Skip to main content
. 2021 Jul 1;39(8):901–912. doi: 10.1007/s40273-021-01059-w

Table 3.

Results of the mixed-effects logit regression model of participant preference

Attribute level OR (95% CI)
Australia, n = 477 Canada, n = 471 Netherlands, n = 481 Sweden, n = 476 UK, n = 477
Alternative-specific constant (Ref: treatment A [left column])

1.628 (1.487–1.783)

p < 0.001

2.013 (1.812–2.236)

p < 0.001

1.525 (1.393–1.670)

p < 0.001

1.350 (1.237–1.472)

p < 0.001

1.455 (1.326–1.595)

p < 0.001

Reduction in life expectancy, years

0.628 (0.601–0.657)

p < 0.001

0.587 (0.558–0.616)

p < 0.001

0.631 (0.603–0.659)

p < 0.001

0.624 (0.598–0.651)

p < 0.001

0.582 (0.554–0.612)

p < 0.001

Frequency of treatment administration (Ref: every 2 weeks, 1 h)
 Every 8 weeks, 3 h

1.193 (1.032–1.380)

p = 0.017

0.966 (0.825–1.132)

p = 0.668

1.042 (0.902–1.203)

p = 0.580

1.511 (1.310–1.744)

p < 0.001

1.132 (0.982–1.306)

p = 0.088

 Every 8 weeks, 1 h

1.450 (1.285–1.638)

p < 0.001

1.305 (1.151–1.480)

p < 0.001

1.336 (1.182–1.510)

p < 0.001

1.946 (1.724–2.196)

p < 0.001

1.273 (1.130–1.434)

p < 0.001

Risk of meningitis (Ref: no increased risk)
 1% risk in next 5 years (low risk)

0.716 (0.640–0.800)

p < 0.001

0.835

(0.741–0.941)

p = 0.003

0.688

(0.614–0.770)

p < 0.001

0.682

(0.610–0.763)

p < 0.001

0.716

(0.638–0.804)

p < 0.001

 1% risk in next 2 years (moderate risk)

0.477 (0.417–0.545)

p < 0.001

0.537 (0.468–0.615)

p < 0.001

0.545 (0.476–0.623)

p < 0.001

0.555 (0.491–0.626)

p < 0.001

0.535 (0.470–0.609)

p < 0.001

Need for hospitalization in the next year (Ref: not admitted to hospital)
 In general ward, no intensive care

0.696 (0.618–0.783)

p < 0.001

0.724 (0.635–0.827)

p < 0.001

0.587 (0.519–0.663)

p < 0.001

0.639 (0.566–0.721)

p < 0.001

0.627 (0.556–0.708)

p < 0.001

 In intensive care and general ward

0.403 (0.349–0.465)

p < 0.001

0.330 (0.281–0.387)

p < 0.001

0.327 (0.280–0.381)

p < 0.001

0.441 (0.386–0.503)

p < 0.001

0.359 (0.307–0.419)

p < 0.001

Risk of impaired kidney function in the next year (Ref: no risk of impaired kidney function)
 5% chance of moderate kidney damage

0.393 (0.343–0.450)

p < 0.001

0.325 (0.279–0.379)

p < 0.001

0.364 (0.314–0.422)

p < 0.001

0.391 (0.340–0.449)

p < 0.001

0.417 (0.362–0.480)

p < 0.001

 5% chance of kidney failure

0.049 (0.037–0.064)

p < 0.001

0.027 (0.019–0.037)

p < 0.001

0.045 (0.034–0.059)

p < 0.001

0.042 (0.032–0.055)

p < 0.001

0.056 (0.043–0.072)

p < 0.001

For categorical variables, an OR >1.0 indicates that the attribute level has a higher odds of being chosen by the individual over the Ref; an OR < 1.0 indicates that the attribute level has a lower odds of being chosen over the Ref. For life expectancy (continuous variable), an OR < 1.0 indicates that for every year of life lost, treatments had a lower odds of being chosen

Marginal rates of substitution were obtained by taking a ratio of the coefficients for two attributes, where the coefficient = ln(OR)

CI confidence interval, OR odds ratio, Ref reference level